跳至主要内容
临床试验/CTRI/2019/05/019230
CTRI/2019/05/019230已完成2 期

Randomized Controlled clinical trial of Parpatadyarishta in the management of Vatashthila with special reference to Benign Prostatic Hyperplasia.

CSMSS AYURVED MAHAVIDYALAYA0 个研究点目标入组 94 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of age between 40 years to 70 years who are diagnosed case of benign Prostatic Hyperplasia.
  • 2.Patients having International Prostate Symptom Score (IPSS) [9] of mild to moderate score (IPSS <19).
  • 3.Patients having post voiding residue of more than 200 ml.[9]
  • 4.Patient Having PSA lower than 4.0 ng/mL[9]
  • 5.Prostate Weight less than 60 gm.
  • 6.Patients and/or his signatory guardian/responsible person had understood the Consent in his own language and willing to follow the suggestion through the assessment period. (i.e. follow up intervals, medicine dose and suggested investigation and examination

排除标准

  • 1.Diagnosed case of bladder & prostate cancer.
  • 2.Any prior surgery which could induce dysuria.
  • 3.Patients having urinary flow less than 5ml/sec.
  • 4.Patient having acute urinary tract infection
  • 5.Urethral Stricture.

研究者

发起方
CSMSS AYURVED MAHAVIDYALAYA

相似试验

se Of Parpatadyarishta in the management of Prostate... | 临床试验